ロード中...
Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers
BACKGROUND: Direct primary care provision of first-trimester medical abortion could potentially address inequitable abortion access in Canada. However, when Health Canada approved the combination medication Mifegymiso® (mifepristone 200 mg/misoprostol 800 mcg) for medical abortion in July 2015, we h...
保存先:
| 出版年: | Pilot Feasibility Stud |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6839244/ https://ncbi.nlm.nih.gov/pubmed/31720004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-019-0520-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|